Ghana — Nuts and Edible Seeds

← back to leaderboard

Ghana received 23 FDA import refusals in Nuts and Edible Seeds between 2023-Q4 and 2026-Q3. Volume peaked at 4 in 2025-Q1, with the trend falling year-on-year. The most-cited issues are salmonella, nutrit lbl, and unapproved. No trade baseline is published for this commodity from Ghana, so no per-$1B rate is shown here.

Of these, 21 were hazard refusals and 2 were paperwork refusals.

Exporting from Ghana? Get an email when shipments from Ghana are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q4 2023-Q4: 0 0 2024-Q1 2024-Q1: 0 3 2024-Q2 2024-Q2: 3 3 2024-Q3 2024-Q3: 3 3 2024-Q4 2024-Q4: 3 4 2025-Q1 2025-Q1: 4 3 2025-Q2 2025-Q2: 3 1 2025-Q3 2025-Q3: 1 3 2025-Q4 2025-Q4: 3 2 2026-Q1 2026-Q1: 2 0 2026-Q2 2026-Q2: 0 1 2026-Q3 2026-Q3: 1

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Other-Nuts 22 13,968 salmonella
Groundnut 1 unapproved

Recent rejections